Scope and limitations of MALDI-TOF MS blood serum peptide profiling in cancer diagnostics

Serum samples (33 healthy women, 34 ovarian cancer, 28 colorectal cancer, 34 syphilis patients and 136 patients with various benign gynecological diseases) were analyzed by MALDI-TOF MS peptide profiling and respective predictive models were generated by genetic and supervised neural network algorithms. Classification models for pathology versus healthy control showed up to 100% sensitivity and specificity for all target diseases. However, the specificity dropped to unsatisfactory 25–40% in case of target versus nontarget disease diagnostics. Expansion of the control group to an artificial “nominal control” group by adding profiles of benign gynecological diseases considerably improved specificity of the models distinguishing ovarian cancer from healthy control and benign gynecological diseases. The suggested version of MALDI-TOF MS profiling of sera could be applied to differentiate between cancers and benign neoplasms of the same localization which is a challenging task for classical methods. To increase the specificity of diagnostic methods based on peptidome analysis of blood samples, it is necessary to identify sets of concrete peptide structures which qualitatively or quantitatively differ among patients with different diseases. © 2016, Pleiades Publishing, Ltd.

Authors
Ivanova O.M.1 , Ziganshin R.H.1 , Arapidi G.P.1, 2 , Kovalchuk S.I.1 , Azarkin I.V.1 , Sorokina A.V. 3 , Govorun V.M.1, 4 , Radzinsky V.E. 3 , Ivanov V.T.1
Editors
-
Publisher
-
Number of issue
5
Language
English
Pages
497-505
Status
Published
Department
-
Number
-
Volume
42
Year
2016
Organizations
  • 1 Department of Proteomics, Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, GSP-7, Moscow, 117997, Russian Federation
  • 2 Faculty of Molecular and Biological Physics, Moscow Institute of Physics and Technology, Institutskii per. 9, Dolgoprudny, Moscow oblast, 141700, Russian Federation
  • 3 Department of Obstetrics and Gynecology with the course of Perinatology, Medical faculty, Peoples’ Friendship University of Russia, ul. Miklukho-Maklaya 8, Moscow, 117198, Russian Federation
  • 4 Institute of Physical-Chemical Medicine, Federal Agency for Health Care and Social Development, ul. Malaya Pirogovskaya 1a, Moscow, 119992, Russian Federation
Keywords
benign gynecological diseases; colorectal cancer; diagnostics; MALDI-TOF MS peptide profiling; ovarian cancer; serum
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/3845/